Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer. – UroToday
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.UroTodayThere is a critical unmet clinical need for bladder cancer immunotherapies capable of inducing durable antitumor immunity. We have show… Continue reading
